Sep. 12, 2024 — Researchers have developed a new method that could be a significant step in the treatment of chronic kidney disease. The method can predict the progression of the disease ...

There are various ways you can keep your kidneys healthy, from staying well hydrated and exercising regularly to maintaining ...

Kidney disease in cats happens when one or both kidneys stop working correctly. There are two types of cat kidney disease—acute (sudden) and chronic. Cats usually don't show symptoms until the disease ...

According to GlobalData, Phase I drugs for Kidney Disease (Nephropathy) have a 71% phase transition success rate (PTSR) indication benchmark for progressing into Phase II. GlobalData’s report assesses ...

A Travere Therapeutics drug for a rare disease that can progress to kidney failure has converted its status to full FDA approval, strengthening the product’s case to compete against two other ...

has granted full approval to Filspari ® (sparsentan) to slow kidney function decline in adults with primary immunoglobulin A (IgA) nephropathy who are at risk for disease progression. Filspari ...

If you have chronic kidney disease (CKD), some foods should be avoided, while others are beneficial to include in your diet. Adjusting what you eat is often a key part of treatment. Learn more ...

According to GlobalData, Phase III drugs for Anemia in Chronic Kidney Disease (Renal Anemia) have a 63% phase transition success rate (PTSR) indication benchmark for progressing into Pre-Registration.

The submission, made on Tuesday, aims to secure approval for OLC's use in treating hyperphosphatemia in patients with chronic kidney disease (CKD) on dialysis. OLC, which utilizes proprietary ...

Immunoglobulin A nephropathy (known as IgA nephropathy or Berger's disease) is a rare kidney disease that occurs when the ...

The FDA has converted Filspari’s conditional nod in the kidney disease IgA nephropathy (IgAN) into a full approval. As part of the conversion Thursday, the FDA has removed a specific urine ...